Product analysis
Raw Resveratrol 350 mg offers resveratrol alongside additional blends. Missing form and blend details make it harder to tell precisely what those ingredients contribute.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The resveratrol form and blend contents are not disclosed clearly enough to compare quality. A blend total does not identify the preparations it contains.
Ingredient Transparency50
Amounts are listed for the main entries, but a reliable resveratrol serving amount remains unresolved. Neither blend discloses its individual components, and the ingredient forms are missing.
Value For Money40
Value based on resveratrol remains uncertain. The unresolved amount of the relevant resveratrol form prevents a dependable comparison of cost against the active supplied.
Customer Satisfaction87
Customer ratings are favorable across a large body of feedback. That supports a broad picture of satisfaction without establishing cardiovascular benefits.
Product Focus30
Resveratrol is the identifiable focus, but its contribution to cardiovascular support remains uncertain. Unresolved serving details and unidentified blend components limit a clearer view of the formula.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.68
- Customer rating
- 4.7 · 3,469 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
RAW Resveratrol Blend | 578 mg | |
RAW Organic Antioxidant Blend | 25 mg | |
Raw Probiotic & Enzyme Blend | 16 mg |
How this ingredient is rated
Composition and Label Disclosure77
Explicit Label Detail
Trans-Resveratrol Concentration Disclosure
Composition and Label Disclosure100
Resveratrol Amount Disclosure
Commercial Price and Usability75
Cost per 250 mg Declared Trans-Resveratrol
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
- Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.
- Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases.
- Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial.
- Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.
- Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis.
- Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.
- One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.
- Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.
- Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.
- Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - A randomized controlled trial.
- Resveratrol levels and all-cause mortality in older community-dwelling adults.
- Impact of Resveratrol Supplementation on Human Sirtuin 1: A Grading of Recommendations Assessment, Development and Evaluation-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.
- Trans-resveratrol reduces visible signs of skin ageing in healthy adult females over 40: an 8-week randomized placebo-controlled trial.
- Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis.
- Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
- Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance.
- Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.